READ: “Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates.” Burdo et al. @templemedschool (ORIP support through P40OD012217, U42OD021458) #HIVResearch #ScienceTwitter https://t.co/UKMEpq5B9O https://t.co/2JwkA01bHj
Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates https://t.co/TSKS1sIFUc
@michael_nielsen Varies a lot based on cell type, guide sequence, and how much immune activation you're ok with. Lot's of research on new vehicles and vectors to improve this. This study uses CRISPR to chop out integrated HIV copies in monkeys across many
RT @ExcisionBio: Today Excision announced our #GeneTherapy, in partnership with @templemedschool, publication of pre-clinical data supporti…